Capital Flow Monitor · Sponsors · CIK 1645460
Cue Biopharma, Inc.
40 GUEST STREET, BOSTON, MA, 02135 · 617-949-2680
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$50.0M
Sold
$50.0M
% sold
100.0%
Investors
4
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-22 | D ·current | 506(b) | $50.0M | $50.0M | 100.0% | 4 | EDGAR ↗ |
| 2026-05-14 | D | 506(b) | $30.0M | $30.0M | 100.0% | 118 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Shao-Lee Lin — Executive Officer / Director, Boston, MA
- Dominic Borie — Executive Officer, Boston, MA
- Sumita Ray — Executive Officer, Boston, MA
- Daniel Camardo — Director, Boston, MA
- Pamela Garzone — Director, Boston, MA
- Viola Meehan — Director, Boston, MA
- Pasha Sarraf — Director, Boston, MA
- Michael Meluzio — Executive Officer, Boston, MA
Placement agents
- Newbridge Securities Corporation · 5 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.